What is Acadia Healthcar's earnings per share (EPS)?

Acadia Healthcar (ACHC) reported diluted earnings per share of $-12.16 for fiscal year 2025. This represents a -537.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Acadia Healthcar Financials

ACHC

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Acadia Healthcar (ACHC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 29/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Growth

Acadia Healthcar's revenue grew 5.0% year-over-year to $3.3B, a solid pace of expansion. This earns a growth score of 42/100.

Leverage

Acadia Healthcar carries a low D/E ratio of 1.27, meaning only $1.27 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 76/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Acadia Healthcar's current ratio of 1.55 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 27/100, which could limit financial flexibility.

Cash Flow

While Acadia Healthcar generated $131.9M in operating cash flow, capex of $571.8M consumed most of it, leaving -$439.9M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Acadia Healthcar generates a -56.6% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from 8.3% the prior year.

Piotroski F-Score Neutral

5/9

Acadia Healthcar passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

-0.12x

For every $1 of reported earnings, Acadia Healthcar generates $-0.12 in operating cash flow ($131.9M OCF vs -$1.1B net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3.3B

YoY+5.0%

5Y CAGR+9.7%

Acadia Healthcar generated $3.3B in revenue in fiscal year 2025. This represents an increase of 5.0% from the prior year.

EBITDA

N/A

Net Income

-$1.1B

YoY-531.4%

Acadia Healthcar reported -$1.1B in net income in fiscal year 2025. This represents a decrease of 531.4% from the prior year.

EPS (Diluted)

$-12.16

YoY-537.4%

Acadia Healthcar earned $-12.16 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 537.4% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$439.9M

YoY+21.5%

Acadia Healthcar generated -$439.9M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 21.5% from the prior year.

Cash & Debt

$133.2M

YoY+74.6%

5Y CAGR-18.9%

10Y CAGR+28.1%

Acadia Healthcar held $133.2M in cash against $2.5B in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

90M

YoY-1.4%

5Y CAGR+0.5%

10Y CAGR+2.5%

Acadia Healthcar had 90M shares outstanding in fiscal year 2025. This represents a decrease of 1.4% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

-33.3%

YoY-41.4pp

5Y CAGR-1.1pp

Acadia Healthcar's net profit margin was -33.3% in fiscal year 2025, showing the share of revenue converted to profit. This is down 41.4 percentage points from the prior year.

Return on Equity

-56.6%

YoY-64.9pp

5Y CAGR-21.2pp

10Y CAGR-63.3pp

Acadia Healthcar's ROE was -56.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 64.9 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$50.0M

Acadia Healthcar spent $50.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

$571.8M

YoY-17.2%

5Y CAGR+20.5%

10Y CAGR+7.6%

Acadia Healthcar invested $571.8M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 17.2% from the prior year.

ACHC Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$3.3B+5.0%	$3.2B+7.7%	$2.9B+12.2%	$2.6B+12.8%	$2.3B+10.7%	$2.1B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$177.6M+13.3%	$156.8M+2.3%	$153.3M+23.3%	$124.3M+14.9%	$108.2M+10.6%	$97.8M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	-$138.9M-19.3%	-$116.4M-41.7%	-$82.1M-17.7%	-$69.8M+9.4%	-$77.0M+51.3%	-$158.1M
Income Tax	$26.0M-66.4%	$77.4M+898.0%	-$9.7M-110.3%	$94.1M+39.3%	$67.6M+66.4%	$40.6M
Net Income	-$1.1B-531.4%	$255.6M+1279.7%	-$21.7M-107.9%	$273.1M+43.3%	$190.6M+128.4%	-$672.1M
EPS (Diluted)	$-12.16-537.4%	$2.78+1258.3%	$-0.24-108.1%	$2.98+41.9%	$2.10+127.7%	$-7.59

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$821.5M-3.5%	$851.6M-2.0%	$869.2M+12.8%	$770.5M-0.5%	$774.2M-5.1%	$815.6M+2.5%	$796.0M+3.6%	$768.1M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	-$37.9M-3.6%	-$36.6M-4.2%	-$35.1M-20.4%	-$29.2M+3.0%	-$30.1M-0.5%	-$29.9M-2.6%	-$29.2M-7.1%	-$27.2M
Income Tax	$7.8M+370.2%	$1.7M-86.2%	$12.1M+174.0%	$4.4M-1.7%	$4.5M-83.5%	$27.2M+6.1%	$25.6M+27.7%	$20.1M
Net Income	-$1.2B-3348.7%	$36.2M+20.3%	$30.1M+259.8%	$8.4M-74.3%	$32.6M-52.1%	$68.1M-13.2%	$78.5M+2.7%	$76.4M
EPS (Diluted)	N/A	$0.40+21.2%	$0.33+266.7%	$0.09	N/A	$0.74-12.9%	$0.85+2.4%	$0.83

ACHC Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$5.5B-7.2%	$6.0B+11.2%	$5.4B+7.4%	$5.0B+4.6%	$4.8B-26.6%	$6.5B
Current Assets	$814.1M+41.0%	$577.5M-3.1%	$596.0M+17.8%	$506.1M+2.2%	$495.0M-80.4%	$2.5B
Cash & Equivalents	$133.2M+74.6%	$76.3M-23.8%	$100.1M+2.5%	$97.6M-27.0%	$133.8M-64.7%	$378.7M
Inventory	$5.7M+0.6%	$5.7M+6.7%	$5.3M+4.2%	$5.1M+6.3%	$4.8M-1.3%	$4.9M
Accounts Receivable	$440.6M+20.6%	$365.3M+1.1%	$361.5M+12.1%	$322.4M+14.6%	$281.3M+2.8%	$273.6M
Goodwill	$1.3B-42.8%	$2.3B+1.7%	$2.2B+0.1%	$2.2B+1.0%	$2.2B+4.5%	$2.1B
Total Liabilities	$3.4B+22.4%	$2.8B+11.9%	$2.5B+18.4%	$2.1B-4.5%	$2.2B-51.9%	$4.5B
Current Liabilities	$525.2M-9.1%	$577.9M-34.8%	$885.8M+128.1%	$388.3M-4.1%	$404.9M-69.1%	$1.3B
Long-Term Debt	$2.5B+31.5%	$1.9B+40.0%	$1.3B-1.6%	$1.4B-7.7%	$1.5B-50.2%	$3.0B
Total Equity	$1.9B-36.6%	$3.1B+10.5%	$2.8B-1.1%	$2.8B+11.7%	$2.5B+32.5%	$1.9B
Retained Earnings	-$765.8M-297.7%	$387.3M+194.1%	$131.7M-14.1%	$153.4M+228.1%	-$119.8M+61.4%	-$310.4M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$5.5B-13.8%	$6.4B+1.7%	$6.3B+2.6%	$6.1B+3.2%	$6.0B+1.5%	$5.9B+3.4%	$5.7B+2.9%	$5.5B
Current Assets	$814.1M+8.8%	$748.0M+8.2%	$691.6M+8.2%	$639.0M+10.6%	$577.5M-11.4%	$652.1M+1.1%	$645.2M+5.6%	$610.8M
Cash & Equivalents	$133.2M+12.3%	$118.7M-9.7%	$131.4M+44.0%	$91.2M+19.6%	$76.3M-7.1%	$82.1M+6.5%	$77.2M-0.2%	$77.3M
Inventory	$5.7M-9.0%	$6.2M+7.4%	$5.8M+1.9%	$5.7M+1.0%	$5.7M+2.5%	$5.5M-7.9%	$6.0M+4.2%	$5.7M
Accounts Receivable	$440.6M+2.3%	$430.8M+5.5%	$408.5M+3.0%	$396.6M+8.6%	$365.3M-4.8%	$383.9M-1.4%	$389.4M+0.8%	$386.2M
Goodwill	$1.3B-43.3%	$2.3B+0.4%	$2.3B0.0%	$2.3B+0.5%	$2.3B0.0%	$2.3B+0.2%	$2.3B0.0%	$2.3B
Total Liabilities	$3.4B+8.5%	$3.1B+1.2%	$3.1B+3.7%	$3.0B+7.5%	$2.8B+1.5%	$2.7B+4.2%	$2.6B+2.8%	$2.5B
Current Liabilities	$525.2M+1.4%	$517.9M-1.1%	$523.7M+10.6%	$473.4M-18.1%	$577.9M-5.2%	$609.5M+11.5%	$546.5M+13.3%	$482.3M
Long-Term Debt	$2.5B+8.2%	$2.3B+1.7%	$2.2B+2.9%	$2.2B+16.2%	$1.9B+4.2%	$1.8B+1.7%	$1.8B-1.1%	$1.8B
Total Equity	$1.9B-37.5%	$3.1B+1.4%	$3.1B+1.2%	$3.0B-1.0%	$3.1B+1.4%	$3.0B+2.7%	$3.0B+3.0%	$2.9B
Retained Earnings	-$765.8M-286.0%	$411.7M+9.7%	$375.4M+7.7%	$348.5M-10.0%	$387.3M+9.2%	$354.7M+23.8%	$286.6M+37.7%	$208.1M

ACHC Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$131.9M+1.7%	$129.7M-71.9%	$462.3M+21.5%	$380.6M+1.6%	$374.5M-43.2%	$658.8M
Capital Expenditures	$571.8M-17.2%	$690.4M+62.8%	$424.1M+43.2%	$296.1M+21.0%	$244.8M+8.8%	$225.0M
Free Cash Flow	-$439.9M+21.5%	-$560.7M-1567.5%	$38.2M-54.7%	$84.4M-34.9%	$129.7M-70.1%	$433.8M
Investing Cash Flow	-$556.2M+24.5%	-$736.5M-85.4%	-$397.2M-29.9%	-$305.8M-130.2%	$1.0B+459.5%	-$281.8M
Financing Cash Flow	$481.3M-17.5%	$583.0M+1029.9%	-$62.7M+43.5%	-$110.9M+93.2%	-$1.6B-3077.8%	-$51.5M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$50.0M	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	-$86.3M-217.9%	$73.2M-45.2%	$133.5M+1063.2%	$11.5M-90.2%	$116.7M-28.5%	$163.1M-4.7%	$171.1M+153.3%	-$321.3M
Capital Expenditures	$93.2M-31.6%	$136.2M-18.8%	$167.7M-3.9%	$174.6M-14.2%	$203.5M+7.0%	$190.2M+23.3%	$154.2M+8.3%	$142.4M
Free Cash Flow	-$179.5M-184.8%	-$63.0M-84.1%	-$34.2M+79.0%	-$163.2M-88.0%	-$86.8M-220.2%	-$27.1M-260.4%	$16.9M+103.6%	-$463.7M
Investing Cash Flow	-$92.4M+28.8%	-$129.8M+13.9%	-$150.8M+17.7%	-$183.2M+9.9%	-$203.3M-5.3%	-$193.1M-24.2%	-$155.5M+15.8%	-$184.6M
Financing Cash Flow	$193.3M+341.1%	$43.8M-23.7%	$57.5M-69.2%	$186.7M+131.1%	$80.8M+131.5%	$34.9M+320.9%	-$15.8M-103.3%	$483.1M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$0	$0-100.0%	$3.2M-93.3%	$46.9M	N/A	N/A	N/A	N/A

ACHC Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-33.3%-41.4pp	8.1%+8.8pp	-0.7%-11.2pp	10.5%+2.2pp	8.2%+40.4pp	-32.2%
Return on Equity	-56.6%-64.9pp	8.3%+9.1pp	-0.8%-10.5pp	9.7%+2.1pp	7.6%+43.0pp	-35.4%
Return on Assets	-20.0%-24.2pp	4.3%+4.7pp	-0.4%-5.9pp	5.5%+1.5pp	4.0%+14.3pp	-10.3%
Current Ratio	1.55+0.6	1.00+0.3	0.67-0.6	1.30+0.1	1.22-0.7	1.93
Debt-to-Equity	1.27+0.7	0.61+0.1	0.480.0	0.49-0.1	0.59-1.0	1.56
FCF Margin	-13.3%+4.5pp	-17.8%-19.1pp	1.3%-1.9pp	3.2%-2.4pp	5.6%-15.2pp	20.8%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-143.3%-147.6pp	4.3%+0.8pp	3.5%+2.4pp	1.1%-3.1pp	4.2%-4.1pp	8.3%-1.5pp	9.9%-0.1pp	10.0%
Return on Equity	-60.4%-61.6pp	1.2%+0.2pp	1.0%+0.7pp	0.3%-0.8pp	1.1%-1.2pp	2.3%-0.4pp	2.7%-0.0pp	2.7%
Return on Assets	-21.3%-21.9pp	0.6%+0.1pp	0.5%+0.3pp	0.1%-0.4pp	0.5%-0.6pp	1.2%-0.2pp	1.4%0.0pp	1.4%
Current Ratio	1.55+0.1	1.44+0.1	1.32-0.0	1.35+0.4	1.00-0.1	1.07-0.1	1.18-0.1	1.27
Debt-to-Equity	1.27+0.5	0.730.0	0.73+0.0	0.72+0.1	0.61+0.0	0.600.0	0.60-0.0	0.63
FCF Margin	-21.9%-14.5pp	-7.4%-3.5pp	-3.9%+17.2pp	-21.2%-10.0pp	-11.2%-7.9pp	-3.3%-5.4pp	2.1%+62.5pp	-60.4%

Similar Companies

Lifestance Health Group, Inc. LFST

$2.4B

Addus Homecare Corp ADUS

$1.7B

Amedisys Inc AMED

$3.3B

Surgery Partners Inc SGRY

$1.5B

CONCENTRA GROUP HOLDINGS PAREN CON

$2.8B

Frequently Asked Questions

What is Acadia Healthcar's annual revenue?

Acadia Healthcar (ACHC) reported $3.3B in total revenue for fiscal year 2025. This represents a 5.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Acadia Healthcar's revenue growing?

Acadia Healthcar (ACHC) revenue grew by 5% year-over-year, from $3.2B to $3.3B in fiscal year 2025.

Is Acadia Healthcar profitable?

No, Acadia Healthcar (ACHC) reported a net income of -$1.1B in fiscal year 2025, with a net profit margin of -33.3%.

How much debt does Acadia Healthcar have?

As of fiscal year 2025, Acadia Healthcar (ACHC) had $133.2M in cash and equivalents against $2.5B in long-term debt.

What is Acadia Healthcar's net profit margin?

Acadia Healthcar (ACHC) had a net profit margin of -33.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Acadia Healthcar's return on equity (ROE)?

Acadia Healthcar (ACHC) has a return on equity of -56.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Acadia Healthcar's free cash flow?

Acadia Healthcar (ACHC) generated -$439.9M in free cash flow during fiscal year 2025. This represents a 21.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Acadia Healthcar's operating cash flow?

Acadia Healthcar (ACHC) generated $131.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Acadia Healthcar's total assets?

Acadia Healthcar (ACHC) had $5.5B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Acadia Healthcar's capital expenditures?

Acadia Healthcar (ACHC) invested $571.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Acadia Healthcar buy back shares?

Yes, Acadia Healthcar (ACHC) spent $50.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Acadia Healthcar have outstanding?

Acadia Healthcar (ACHC) had 90M shares outstanding as of fiscal year 2025.

What is Acadia Healthcar's current ratio?

Acadia Healthcar (ACHC) had a current ratio of 1.55 as of fiscal year 2025, which is generally considered healthy.

What is Acadia Healthcar's debt-to-equity ratio?

Acadia Healthcar (ACHC) had a debt-to-equity ratio of 1.27 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Acadia Healthcar's return on assets (ROA)?

Acadia Healthcar (ACHC) had a return on assets of -20.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Acadia Healthcar's Piotroski F-Score?

Acadia Healthcar (ACHC) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Acadia Healthcar's earnings high quality?

Acadia Healthcar (ACHC) has an earnings quality ratio of -0.12x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Acadia Healthcar?

Acadia Healthcar (ACHC) scores 29 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.